HPGD and cancer: The degradation of prostaglandins (PG) by 15-hydroxyprostaglandin dehydrogenase (15-PGDH) is one of the crucial steps in regulating PG levels, especially prostaglandin E2 (PGE2), which is known to play major roles in carcinogenesis, cancer progression, and tissue regeneration1–3.